Novavax stock took a hit in mid-October after the FDA placed its request to begin testing two new products on hold. Is NVAX stock a sell?
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
NVAX's COVID-19-flu combination and stand-alone flu vaccines have been placed on hold after a study participant who took the combo shot reported nerve damage.